J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India · Delayed Price · Currency is INR 2,179.90
+10.60 (0.49%)
Jun 8, 2026, 3:29 PM IST
NSE:JBCHEPHARM Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 348,750 | 331,265 | 252,540 | 255,986 | 152,503 | 121,735 | |
Market Cap Growth | 35.98% | 31.17% | -1.35% | 67.86% | 25.27% | 25.65% |
Enterprise Value | 336,572 | 325,732 | 249,373 | 256,557 | 154,282 | 114,656 |
Last Close Price | 2172.80 | 2055.69 | 1599.44 | 1612.58 | 958.95 | 757.50 |
PE Ratio | 49.16 | 46.69 | 38.29 | 46.32 | 37.21 | 31.59 |
PS Ratio | 8.41 | 7.99 | 6.45 | 7.35 | 4.84 | 5.02 |
PB Ratio | 8.38 | 7.97 | 7.36 | 8.76 | 6.15 | 5.69 |
P/TBV Ratio | 12.14 | 11.53 | 12.27 | 17.33 | 13.86 | 8.66 |
P/FCF Ratio | 56.18 | 53.37 | 31.38 | 37.99 | 27.42 | 113.49 |
P/OCF Ratio | 49.54 | 47.06 | 27.98 | 31.97 | 24.26 | 71.55 |
EV/Sales Ratio | 8.11 | 7.85 | 6.37 | 7.36 | 4.90 | 4.73 |
EV/EBITDA Ratio | 30.47 | 29.87 | 24.48 | 29.11 | 21.92 | 21.29 |
EV/EBIT Ratio | 36.47 | 35.30 | 29.00 | 34.01 | 26.07 | 24.19 |
EV/FCF Ratio | 54.22 | 52.48 | 30.98 | 38.08 | 27.74 | 106.89 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.13 | 0.23 | 0.03 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.03 | 0.42 | 0.81 | 0.10 |
Debt / FCF Ratio | 0.01 | 0.01 | 0.04 | 0.56 | 1.03 | 0.51 |
Net Debt / Equity Ratio | -0.29 | -0.29 | -0.12 | -0.03 | 0.12 | 0.00 |
Net Debt / EBITDA Ratio | -1.12 | -1.12 | -0.41 | -0.09 | 0.43 | 0.00 |
Net Debt / FCF Ratio | -1.96 | -1.96 | -0.52 | -0.12 | 0.55 | -0.02 |
Asset Turnover | 0.90 | 0.90 | 0.95 | 0.92 | 1.02 | 1.00 |
Inventory Turnover | 2.21 | 2.21 | 2.63 | 2.60 | 2.85 | 2.29 |
Quick Ratio | 3.45 | 3.45 | 2.02 | 1.34 | 1.57 | 1.70 |
Current Ratio | 4.92 | 4.92 | 3.04 | 2.13 | 2.76 | 3.27 |
Return on Equity (ROE) | 18.69% | 18.69% | 20.75% | 20.45% | 17.75% | 19.54% |
Return on Assets (ROA) | 12.48% | 12.48% | 13.00% | 12.49% | 12.01% | 12.22% |
Return on Invested Capital (ROIC) | 22.20% | 23.10% | 21.84% | 19.73% | 17.76% | 21.95% |
Return on Capital Employed (ROCE) | 21.10% | 21.10% | 23.60% | 24.10% | 19.70% | 21.30% |
Earnings Yield | 2.03% | 2.14% | 2.61% | 2.16% | 2.69% | 3.17% |
FCF Yield | 1.78% | 1.87% | 3.19% | 2.63% | 3.65% | 0.88% |
Dividend Yield | 1.01% | 1.07% | 0.97% | 0.76% | 0.92% | 1.09% |
Payout Ratio | 44.16% | 44.16% | 35.94% | 28.41% | 31.13% | 33.10% |
Buyback Yield / Dilution | -0.59% | -0.59% | -0.07% | -1.26% | -1.23% | -0.10% |
Total Shareholder Return | 0.42% | 0.48% | 0.90% | -0.50% | -0.31% | 0.99% |